Thomas M. Ross is EVP, GLOBAL SALES of MAXCYTE, INC.. Currently has a direct ownership of 25,000 shares of MXCT, which is worth approximately $102,750. The most recent transaction as insider was on Mar 31, 2023, when has been sold 2,607 shares (Common Stock) at a price of $5.0 per share, resulting in proceeds of $13,035. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25K
0% 3M change
Infinity% 12M change
Total Value Held $102,750

Thomas M. Ross Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2023
SELL
Open market or private sale
$13,035 $5.0 p/Share
2,607 Reduced 100.0%
0 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
$5,578 $2.14 p/Share
2,607 Added 50.0%
2,607 Common Stock
Feb 02 2023
SELL
Open market or private sale
$66,787 $5.77 p/Share
11,575 Reduced 100.0%
0 Common Stock
Feb 02 2023
BUY
Exercise of conversion of derivative security
$24,770 $2.14 p/Share
11,575 Added 50.0%
11,575 Common Stock
Feb 01 2023
SELL
Open market or private sale
$99,729 $5.68 p/Share
17,558 Reduced 100.0%
0 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$27,390 $1.56 p/Share
17,558 Added 50.0%
17,558 Common Stock
Jan 05 2023
SELL
Open market or private sale
$47,713 $5.04 p/Share
9,467 Reduced 100.0%
0 Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$9,277 $0.98 p/Share
9,467 Added 50.0%
9,467 Common Stock
Jan 04 2023
SELL
Open market or private sale
$46,405 $5.07 p/Share
9,153 Reduced 100.0%
0 Common Stock
Jan 04 2023
BUY
Exercise of conversion of derivative security
$8,969 $0.98 p/Share
9,153 Added 50.0%
9,153 Common Stock
Jan 03 2023
SELL
Open market or private sale
$53,931 $5.13 p/Share
10,513 Reduced 100.0%
0 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$10,302 $0.98 p/Share
10,513 Added 50.0%
10,513 Common Stock
Dec 05 2022
SELL
Open market or private sale
$79,003 $5.59 p/Share
14,133 Reduced 100.0%
0 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$15,263 $1.08 p/Share
14,133 Added 50.0%
14,133 Common Stock
Dec 02 2022
SELL
Open market or private sale
$90,300 $6.02 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 02 2022
BUY
Exercise of conversion of derivative security
$16,200 $1.08 p/Share
15,000 Added 50.0%
15,000 Common Stock
Nov 02 2022
SELL
Open market or private sale
$39,072 $6.85 p/Share
5,704 Reduced 100.0%
0 Common Stock
Nov 02 2022
BUY
Exercise of conversion of derivative security
$5,475 $0.96 p/Share
5,704 Added 50.0%
5,704 Common Stock
Nov 01 2022
SELL
Open market or private sale
$162,597 $6.94 p/Share
23,429 Reduced 100.0%
0 Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
$19,680 $0.84 p/Share
23,429 Added 50.0%
23,429 Common Stock
Oct 11 2022
SELL
Open market or private sale
$27,876 $6.51 p/Share
4,282 Reduced 100.0%
0 Common Stock
Oct 11 2022
BUY
Exercise of conversion of derivative security
$3,597 $0.84 p/Share
4,282 Added 50.0%
4,282 Common Stock
Oct 10 2022
SELL
Open market or private sale
$160,289 $6.45 p/Share
24,851 Reduced 100.0%
0 Common Stock
Oct 10 2022
BUY
Exercise of conversion of derivative security
$20,875 $0.84 p/Share
24,851 Added 50.0%
24,851 Common Stock
Nov 16 2021
SELL
Open market or private sale
$376,449 $12.08 p/Share
31,163 Reduced 100.0%
0 Common Stock
TMR

Thomas M. Ross

EVP, GLOBAL SALES
Gaithersburg, MD

Track Institutional and Insider Activities on MXCT

Follow MAXCYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MXCT shares.

Notify only if

Insider Trading

Get notified when an Maxcyte, Inc. insider buys or sells MXCT shares.

Notify only if

News

Receive news related to MAXCYTE, INC.

Track Activities on MXCT